Future directions in thrombolysis

Area of Science:

• Cardiology
• Vascular Biology
• Pharmacology

Background:

• Extensive research over 25 years has elucidated the mechanisms and pathogenesis of acute coronary syndromes and occlusive vascular disease.
• Thrombosis is understood to result from vascular injury, making thrombus lysis and prevention of reocclusion critical for treatment.
• Advances in understanding vascular-wall-platelet and platelet-platelet interactions, along with coagulation, have identified numerous drug targets and antithrombotic agents.

Purpose of the Study:

• To review emerging antithrombotic therapies.
• To introduce potential future molecular targets for drug discovery.
• To discuss novel strategies for managing patients with coronary artery disease.

Main Methods:

• Literature review of research on acute coronary syndromes, thrombosis, and antithrombotic therapies.
• Analysis of biological and molecular mechanisms in vascular-wall-platelet and platelet-platelet interactions, and coagulation.
• Synthesis of information on current and future drug discovery targets and patient management strategies.

Main Results:

• Established understanding of thrombosis mechanisms and pathogenesis in coronary artery disease.
• Identification of multiple drug targets and development of numerous antithrombotic drugs.
• Emerging antithrombotic therapies and novel management strategies are under investigation.

Conclusions:

• Continued research has significantly advanced the understanding of coronary artery disease and thrombosis.
• Multiple therapeutic targets and antithrombotic drugs have been developed.
• Future research will focus on novel therapies and management strategies for coronary artery disease.